Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
20.40
+2.26 (12.46%)
May 2, 2025, 4:08 PM HKT
HKG:2190 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 418.11 | 1,087 | 1,205 | 1,418 | 59.56 | Upgrade
|
Short-Term Investments | 804.24 | 355.55 | 545.14 | 1,500 | 100 | Upgrade
|
Trading Asset Securities | 60.54 | 68.74 | 110.23 | 10.52 | 157.7 | Upgrade
|
Cash & Short-Term Investments | 1,283 | 1,511 | 1,861 | 2,929 | 317.26 | Upgrade
|
Cash Growth | -15.09% | -18.80% | -36.47% | 823.19% | 212.53% | Upgrade
|
Accounts Receivable | 1.54 | 1.18 | 1.01 | 0.45 | 0.13 | Upgrade
|
Other Receivables | 14.54 | 12.76 | 11.42 | 5.07 | 6.7 | Upgrade
|
Receivables | 16.08 | 13.94 | 12.43 | 5.52 | 6.82 | Upgrade
|
Inventory | 223.74 | 183.68 | 163.05 | 80.91 | 39.69 | Upgrade
|
Restricted Cash | - | - | 0.65 | - | - | Upgrade
|
Other Current Assets | 6.33 | 8.7 | 25.8 | 8.91 | 6.38 | Upgrade
|
Total Current Assets | 1,529 | 1,717 | 2,063 | 3,024 | 370.14 | Upgrade
|
Property, Plant & Equipment | 665.5 | 578.36 | 338.38 | 212.39 | 122.17 | Upgrade
|
Long-Term Investments | 1,227 | 1,066 | 832.44 | - | - | Upgrade
|
Other Intangible Assets | 28.01 | 9.69 | 9.64 | 4.89 | 7.56 | Upgrade
|
Other Long-Term Assets | 3.31 | 4.28 | 10.65 | 6.8 | 4.1 | Upgrade
|
Total Assets | 3,453 | 3,376 | 3,254 | 3,248 | 503.97 | Upgrade
|
Accounts Payable | 69.37 | 42.44 | 18.26 | 21.58 | 5.44 | Upgrade
|
Accrued Expenses | 72.06 | 70.74 | 70.16 | 39.86 | 19.26 | Upgrade
|
Short-Term Debt | 87 | - | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | - | 50 | - | - | 3.75 | Upgrade
|
Current Portion of Leases | 2.4 | 4.02 | 6.54 | 2.9 | 2.83 | Upgrade
|
Current Unearned Revenue | 16.86 | 19.92 | 9.6 | 3.42 | 0.13 | Upgrade
|
Other Current Liabilities | 86.47 | 130.66 | 47.53 | 29.35 | 20.22 | Upgrade
|
Total Current Liabilities | 334.17 | 317.78 | 152.08 | 97.1 | 51.63 | Upgrade
|
Long-Term Debt | - | - | - | - | 26.25 | Upgrade
|
Long-Term Leases | 1.5 | 1.86 | 7.46 | 6.51 | 1.4 | Upgrade
|
Long-Term Unearned Revenue | 15.89 | 8.67 | - | - | - | Upgrade
|
Total Liabilities | 351.56 | 328.32 | 159.54 | 103.61 | 79.28 | Upgrade
|
Common Stock | 330.18 | 332.4 | 332.4 | 332.4 | 225.06 | Upgrade
|
Additional Paid-In Capital | 2,091 | 2,270 | 2,270 | 2,270 | - | Upgrade
|
Retained Earnings | 65.28 | -481.91 | -403.17 | -289.62 | -361.52 | Upgrade
|
Treasury Stock | -100.7 | -87.59 | -33.79 | -9.15 | - | Upgrade
|
Comprehensive Income & Other | 715.71 | 1,014 | 928.69 | 841.01 | 561.15 | Upgrade
|
Shareholders' Equity | 3,101 | 3,047 | 3,094 | 3,145 | 424.69 | Upgrade
|
Total Liabilities & Equity | 3,453 | 3,376 | 3,254 | 3,248 | 503.97 | Upgrade
|
Total Debt | 90.91 | 55.88 | 14 | 9.41 | 34.22 | Upgrade
|
Net Cash (Debt) | 1,192 | 1,455 | 1,847 | 2,919 | 283.04 | Upgrade
|
Net Cash Growth | -18.08% | -21.21% | -36.75% | 931.49% | 262.10% | Upgrade
|
Net Cash Per Share | 3.63 | 4.43 | 5.59 | 9.91 | 1.45 | Upgrade
|
Filing Date Shares Outstanding | 322.56 | 324.05 | 329.69 | 331.92 | 225.06 | Upgrade
|
Total Common Shares Outstanding | 322.56 | 324.05 | 329.69 | 331.92 | 225.06 | Upgrade
|
Working Capital | 1,195 | 1,399 | 1,911 | 2,927 | 318.51 | Upgrade
|
Book Value Per Share | 9.61 | 9.40 | 9.39 | 9.47 | 1.89 | Upgrade
|
Tangible Book Value | 3,073 | 3,038 | 3,085 | 3,140 | 417.14 | Upgrade
|
Tangible Book Value Per Share | 9.53 | 9.37 | 9.36 | 9.46 | 1.85 | Upgrade
|
Buildings | - | 160.12 | 156.14 | 139.25 | - | Upgrade
|
Machinery | - | 89.41 | 75.65 | 43.25 | 23.25 | Upgrade
|
Construction In Progress | - | 322.96 | 77.99 | 5.85 | 91.4 | Upgrade
|
Leasehold Improvements | - | 32.24 | 21.7 | 13.97 | 13.41 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.